" ’    Gottlieb Trump early on as a favorite among members of the drug    industry .Salim Syed , a biotech analyst at Mizuho , asked    pharma executives who they would Salim Syed, a biotech analyst at Mizuho to see as the next FDA    commissioner    The overwhelming majority ( 72 % ) said    Gottlieb   Gottlieb ’ ’   ’ "    